GOZZETTI ALESSANDRO

Alessandro
Gozzetti
Professore Associato

Contacts

0577586784 [int.0577586784]

Curriculum Vitae

Teaching activities

Completion accademic year: 2024/2025

Course year: 1 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2024/2025
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2022/2023
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2021/2022

Completion accademic year: 2023/2024

Course year: 1 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2023/2024
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2021/2022
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2020/2021

Completion accademic year: 2022/2023

Research

Ultime pubblicazioni:

  • Nardi, F., Del Prete, R., Drago, R., Di Rita, A., Vallone, F.E., Ciofini, S., et al. (2025). Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia. LEUKEMIA, 39(1), 122-133 [10.1038/s41375-024-02442-0]. - view more
  • Sportoletti, P., Laurenti, L., Chiarenza, A., Gaidano, G., Albi, E., Mauro, F.R., et al. (2024). Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. HEMATOLOGICAL ONCOLOGY, 42(1), 1-10 [10.1002/hon.3216]. - view more
  • D'Agostino, M., Bertuglia, G., Rota-Scalabrini, D., Belotti, A., Morè, S., Corradini, P., et al. (2024). Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients. BLOOD, 143(7), 592-596 [10.1182/blood.2023022080]. - view more
  • Boncompagni, G., Tatangelo, V., Lopresti, L., Ulivieri, C., Capitani, N., Tangredi, C., et al. (2024). Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia. CELL DEATH & DISEASE, 15(2) [10.1038/s41419-024-06528-6]. - view more
  • Lopresti, L., Capitani, N., Tatangelo, V., Tangredi, C., Boncompagni, G., Frezzato, F., et al. (2024). p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 12 [10.3389/fcell.2024.1297116]. - view more